Brendan Smith, an analyst from TD Cowen, maintained the Buy rating on Ginkgo Bioworks Holdings (DNA – Research Report). The associated ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at ...

Ginkgo Bioworks Holdings Inc (DNA) stock saw a modest uptick, ending the day at $6.81 which represents a slight increase of $0.58 or 9.31% from the prior close of $6.23. The stock opened at $6.37 and ...

The Functional Genomics product, the flagship offering under Ginkgo Datapoints, available now, delivers large-scale ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock ...